Latest Posts

30

May 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

featured, Press release 2024
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

featured, Press release 2024
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
Try Ontosight® For Free

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President

Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President. Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience.

Prior to joining Innoplexus, Mr. Davlos was the Vice President of Watson, AI & Engineering at IBM. His AI-focused career spans many years of executive technology management and development at among others Reliance Jio and Apple. Mr. Davlos holds many innovations, patents and has received many honors and awards.

“We are very excited to welcome Stratos to Innoplexus at such an important time as we roll out our AI-powered platform for Drug Discovery and Development for various industry stakeholders. His expertise and extensive experience will help us accelerate scaling our AI,“ said Dr. Gunjan Bhardwaj, Founder, and CEO of Innoplexus.

Stratos will be based in California in his global role and will build an Innoplexus Research Lab in the Valley. “I am excited to be a part of a purpose-driven company and continue to innovate with AI for effective and efficient drug discovery. Together with Innoplexus, we will put a dent in the universe for the service of humanity “, said Stratos.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing
on June 27, 2023

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…

Read More